Nkgen Biotech Inc. (NKGN)
Market Open
11 Aug, 13:42
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 01
0
0%
$
666.07K Market Cap
- P/E Ratio
- Div Yield
500 Volume
0 Eps
$ 0.01
Previous Close Want to track NKGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is NKGen Biotech (NKGN) Stock Up 18% Today?
NKGen Biotech (NASDAQ: NKGN ) stock is rocketing higher on Thursday as the clinical-stage biotechnology company prepares to present new biomarker data on SNK01. This is the company's treatment candidate for Alzheimer's disease.
Investorplace | 2 years ago
NKGN Stock Alert: The Alzheimer's News That Has NKGen Biotech Soaring Today
NKGen Biotech (NASDAQ: NKGN ) stock is taking off on Monday after the clinical-stage biotechnology company got an update on its Phase 2 clinical trial. The company says that its Safety Review Committee has given it the go-ahead to start its Phase 2 clinical study of SNK01.
Investorplace | 2 years ago
